Research Paper Volume 12, Issue 11 pp 10506—10516

Modification of graphene oxide by angiopep-2 enhances anti-glioma efficiency of the nanoscaled delivery system for doxorubicin

Figure 1. Characterization of angiopep-2 polypeptide-modified and doxorubicin-loaded graphene oxide (ANG-Dox-GO). (A) The appearance of commercial GO. (B) The representative images of ANG-Dox-GO using atomic force microscopy. (C) The ultraviolet visible absorption spectra of ANG-Dox-GO.